For the Motion: Refers to: "The Motion: There is Evidence That Prostate Cancer Screening Does More Good Than Harm" (European Urology, Volume 50, Issue 2, August 2006, Pages 377-380)

As a urologist with a longstanding special interest in prostate cancer and as the co-ordinator of a large randomised screening study, I certainly hope that in due time the question of whether screening does more good than harm can be answered with a convincing ‘yes’. At the present time, however, we still have to wait for the definitive outcome of the European Randomised Study of Screening for Prostate Cancer (ERSPC) and of the Prostate, Lung, Colon, and Ovary Cancer screening trial (PLCO) of the National Cancer Institute of the USA. The more powerful European trial evaluates the endpoints of prostate cancer mortality and quality of life (QoL) and data should be available within a few years (2008–10). [...]